top of page
NDC | HCPCS | HCPCS Description | NDC Label | Route of Administration |
|---|---|---|---|---|
44567-0701-25 | J0696 | INJECTION, CEFTRIAXONE SODIUM, PER 250 MG | CEFTRIAXONE (USP) 1 GM | IJ |
44567-0701-95 | J0696 | INJECTION, CEFTRIAXONE SODIUM, PER 250 MG | PREMIERPRO RX CEFTRIAXONE (SDV) 1 GM | IJ |
44567-0702-95 | J0696 | INJECTION, CEFTRIAXONE SODIUM, PER 250 MG | PREMIERPRO RX CEFTRIAXONE (SDV) 2 GM | IJ |
44567-0705-10 | J0743 | INJECTION, CILASTATIN SODIUM; IMIPENEM, PER 250 MG | IMIPENEM AND CILASTATIN (SDV;USP) 500 MG-500 MG | IV |
44567-0811-10 | J1806 | INJECTION, ESMOLOL HYDROCHLORIDE (WG CRITICAL CARE) NOT THERAPEUTICALLY EQUIVALENT TO J1805, 10 MG | ESMOLOL HCL (PF,LATEX-FREE) 2500 MG/250 ML | IV |
44567-0812-10 | J1806 | INJECTION, ESMOLOL HYDROCHLORIDE (WG CRITICAL CARE) NOT THERAPEUTICALLY EQUIVALENT TO J1805, 10 MG | ESMOLOL HCL (PF,LATEX-FREE) 2000 MG/100 ML | IV |
44567-0820-10 | J1335 | INJECTION, ERTAPENEM SODIUM, 500 MG | ERTAPENEM (SDV,LYOPHILIZED) 1 GM | IJ |
45802-0127-14 | Q0162 | ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN | ONDANSETRON HYDROCHLORIDE (FILM-COATED) 4 MG | PO |
45802-0127-65 | Q0162 | ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN | ONDANSETRON HYDROCHLORIDE (FILM-COATED) 4 MG | PO |
45802-0205-14 | Q0162 | ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN | ONDANSETRON HYDROCHLORIDE (FILM-COATED) 8 MG | PO |
49999-0003-20 | Q0163 | DIPHENHYDRAMINE HYDROCHLORIDE, 50 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT TIME OF CHEMOTHERAPY TREATMENT NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN | DIPHENHYDRAMINE 25 MG | PO |
49999-0003-30 | Q0163 | DIPHENHYDRAMINE HYDROCHLORIDE, 50 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT TIME OF CHEMOTHERAPY TREATMENT NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN | DIPHENHYDRAMINE HCL 25 MG | PO |
HCPCS Code | Description | Billing Unit | SA Type |
|---|---|---|---|
A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | Each | N |
A7006 | Administration set, with small volume filter pneumatic nebulizer | Each | N |
A7007 | Large voume nebulizer, disposable, unfilled, used with aerosol compressor | Each | N |
A7008 | Large volume nebulizer, disposable, Prefilled, used with aerosol compressor | Each | N |
bottom of page